Komen Foundation

The funding from Susan G. Komen will help support the project's effort to  gather genomic and other data from young breast cancer patients.

NEW YORK (GenomeWeb News) – Pathway Genomics and Susan G. Komen today said they are partnering to educate women about screening options available for detecting a genetic predisposition for breast cancer.

NEW YORK (GenomeWeb News) – Scientists at Washington University in St. Louis and the Institute of Cancer Research in London plan to use a $4 million grant from the Susan G.

By Matt Jones
NEW YORK (GenomeWeb News) – Michigan State University has won a $450,000 grant from the Susan G. Komen for the Cure foundation to conduct studies focused on gene expression in breast cancer tumors.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – The Susan G. Komen for the Cure foundation has granted $3.5 million to a trio of research institutes to study triple-negative breast cancer in African and African-American women.

The team plans to use sequencing to create a polyepitope DNA vaccine that will contain "fragments from each individual mutated protein" for individual patients. They hope to begin human trials for the vaccine within the next two years.

"Identification and validation of mutations in individual breast cancers provides an unprecedented opportunity to target unique tumor antigens with personalized breast cancer vaccines," the researchers wrote in their project abstract.

Despite pleas of breast cancer advocates to maintain access to Avastin using gene markers to identify those most likely to benefit, there is little evidence to suggest that the drug company or regulatory experts are considering this strategy.

The nearly $19 million in funding for PGx research projects is provided through Komen's Promise Grants.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.